129 related articles for article (PubMed ID: 32144465)
1. Enhancers and MYC interplay in hematopoiesis.
Benetatos L; Benetatou A; Vartholomatos G
J Mol Med (Berl); 2020 Apr; 98(4):471-481. PubMed ID: 32144465
[TBL] [Abstract][Full Text] [Related]
2. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
3. Mouse Models of
Ferrad M; Ghazzaui N; Issaoui H; Cook-Moreau J; Denizot Y
Front Immunol; 2020; 11():1564. PubMed ID: 32793219
[TBL] [Abstract][Full Text] [Related]
4. A Myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma.
Hu HM; Arcinas M; Boxer LM
J Biol Chem; 2002 Mar; 277(12):9819-24. PubMed ID: 11777933
[TBL] [Abstract][Full Text] [Related]
5. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
Jain VK; Judde JG; Max EE; Magrath IT
J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism.
Schuijers J; Manteiga JC; Weintraub AS; Day DS; Zamudio AV; Hnisz D; Lee TI; Young RA
Cell Rep; 2018 Apr; 23(2):349-360. PubMed ID: 29641996
[TBL] [Abstract][Full Text] [Related]
7. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
Yan Y; Park SS; Janz S; Eckhardt LA
Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
[TBL] [Abstract][Full Text] [Related]
8. Long-range enhancers on 8q24 regulate c-Myc.
Sotelo J; Esposito D; Duhagon MA; Banfield K; Mehalko J; Liao H; Stephens RM; Harris TJ; Munroe DJ; Wu X
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3001-5. PubMed ID: 20133699
[TBL] [Abstract][Full Text] [Related]
9. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression.
Yochum GS; Cleland R; Goodman RH
Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287
[TBL] [Abstract][Full Text] [Related]
10. What retroviruses teach us about the involvement of c-Myc in leukemias and lymphomas.
Dudley JP; Mertz JA; Rajan L; Lozano M; Broussard DR
Leukemia; 2002 Jun; 16(6):1086-98. PubMed ID: 12040439
[TBL] [Abstract][Full Text] [Related]
11. Far Upstream Element Binding Protein Plays a Crucial Role in Embryonic Development, Hematopoiesis, and Stabilizing Myc Expression Levels.
Zhou W; Chung YJ; Parrilla Castellar ER; Zheng Y; Chung HJ; Bandle R; Liu J; Tessarollo L; Batchelor E; Aplan PD; Levens D
Am J Pathol; 2016 Mar; 186(3):701-15. PubMed ID: 26774856
[TBL] [Abstract][Full Text] [Related]
12. The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.
Lancho O; Herranz D
Trends Cancer; 2018 Dec; 4(12):810-822. PubMed ID: 30470303
[TBL] [Abstract][Full Text] [Related]
13. Selection for c-myc integration sites in polyclonal T-cell lymphomas.
Broussard DR; Mertz JA; Lozano M; Dudley JP
J Virol; 2002 Mar; 76(5):2087-99. PubMed ID: 11836386
[TBL] [Abstract][Full Text] [Related]
14. Mice deficient of
Dave K; Sur I; Yan J; Zhang J; Kaasinen E; Zhong F; Blaas L; Li X; Kharazi S; Gustafsson C; De Paepe A; Månsson R; Taipale J
Elife; 2017 Jun; 6():. PubMed ID: 28583252
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.
Peltenburg LT; Dee R; Schrier PI
Nucleic Acids Res; 1993 Mar; 21(5):1179-85. PubMed ID: 8464702
[TBL] [Abstract][Full Text] [Related]
16. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
17. Aberrant regulation of the IgH 3' enhancer by c-myc in plasmacytoma cells.
Arulampalam V; Grant P; Poellinger L; Pettersson S
Mol Immunol; 1995 Dec; 32(17-18):1369-75. PubMed ID: 8643106
[TBL] [Abstract][Full Text] [Related]
18.
Zimmerman MW; Liu Y; He S; Durbin AD; Abraham BJ; Easton J; Shao Y; Xu B; Zhu S; Zhang X; Li Z; Weichert-Leahey N; Young RA; Zhang J; Look AT
Cancer Discov; 2018 Mar; 8(3):320-335. PubMed ID: 29284669
[TBL] [Abstract][Full Text] [Related]
19. Embryonic Program Activated during Blast Crisis of Chronic Myelogenous Leukemia (CML) Implicates a TCF7L2 and MYC Cooperative Chromatin Binding.
Desterke C; Hugues P; Hwang JW; Bennaceur-Griscelli A; Turhan AG
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517078
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.
Peltenburg LT; Schrier PI
Immunogenetics; 1994; 40(1):54-61. PubMed ID: 8206526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
